Ethics top priority for US biotechnology, says retiring head
The retiring head of the US biotechnology association believes that ethics is the main issue which could derail his industry. “We have paid passionate attention to bioethics issues,” Carl Feldbaum told the Seattle Times. “We have taken them dead seriously. We have gone beyond narrow commercial interests and have tried to contribute, without commandeering, debates about Dolly, stem cells and gene therapy… The mishandling of a bioethics issue could derail us in no time, but hopefully that won’t happen.”
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Could newborns solve the kidney shortage crisis?
Kidneys from newborn babies could be a “game-changing” solution to organ shortage crisis, according to an American study. According to...
Chinese sperm bank pushes the boundaries in its marketing
With a birth rate of 1.09 and a declining population, there is a sense of urgency in China about reversing...
Chinese scientists grow humanized kidneys in pigs
Chinese scientists have successfully created chimeric embryos containing a combination of human and pig cells. When transferred into surrogate pig...
People born from donor gametes in UK will be able to doorknock their dad
As of October 1, 18-year-olds in the United Kingdom conceived with donor gametes will be able to find out who...
British teen dies after doctors refuse her request for experimental treatment
ST, the 19-year-old woman at the centre of a dispute about mental competence and healthcare in Britain, has died of...
Dodging a bullet: how a report recommending ‘chestfeeding’ and inclusive pronouns almost became the norm in British maternity wards
A transgender maternity report commissioned by public health authorities in the UK last year made headlines by recommending the use...